ID
RXII

Integral Derivatives’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Integral Derivatives’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-77,100
Closed -$27K – 1350
2016
Q3 		$27K Sell
77,100
-13,700
-15% -$4.8K ﹤0.01% 971
2016
Q2 		$42K Buy
90,800
+75,800
+505% +$35.1K ﹤0.01% 923
2016
Q1 		$20K Hold
15,000
– – ﹤0.01% 823
2015
Q4 		$22K Hold
15,000
– – ﹤0.01% 1040
2015
Q3 		$24K Buy
+15,000
New +$24K ﹤0.01% 1055

Integral Derivatives's RXII Position: Q4 2016 in Review

Integral Derivatives sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 10,901 shares — an estimated $4K sold.

Integral Derivatives first reported a position in RXII in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Integral Derivatives reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Integral Derivatives sold 10,901 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Integral Derivatives first reported a position in GALENA BIOPHARMA INC COM in Q2 2016 and held it in 2 quarters.
  • Integral Derivatives's GALENA BIOPHARMA INC COM position peaked at $9K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.